# Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators

> **NCT01557842** · PHASE4 · TERMINATED · sponsor: **Biosense Webster, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Ventricular Tachycardia
- Ischemic

## Interventions

- **DRUG:** Drug Treatment
- **DEVICE:** Catheter Ablation

## Key facts

- **NCT ID:** NCT01557842
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06-01
- **Primary completion:** 2014-03-19
- **Final completion:** 2014-03-19
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01557842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01557842, "Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01557842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*